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In this editorial, the value of hyperbaric oxygen therapy in the management of chronic post-concussive syndrome
following mild traumatic brain injury is discussed.
Keywords: Hyperbaric oxygen, Traumatic brain injury, OutcomeTraumatic brain injury (TBI) affects roughly 10 million
people worldwide each year, and is a leading cause of
death and disability among all demographics, dispropor-
tionately affecting young adults [1]. TBI is defined as an
external mechanical insult to the brain in the form of
penetration, acceleration, rotational forces, or blast
waves resulting in temporary or permanent impairment
in brain function. TBI is further categorized by etiology,
damaged area of the brain, and severity (mild, moderate
or severe). In the United States, 80% of TBI cases are
mild, with loss of consciousness less than thirty minutes,
retrograde amnesia of less than one day and Glasgow
Coma Scale (GCS) on presentation of 13–15 [2].
Following even mild TBI, many patients experience a
range of symptoms grouped together under the heading
of post-concussive syndrome (PCS). Symptoms include
alterations in executive function, depression, anxiety,
headache, dizziness, and impairment in memory. Ap-
proximately one in five patients with PCS will experi-
ence these symptoms for greater than six months
following their injury [3]. PCS is a clinical diagnosis, and
many patients with mild TBI will have normal-appearing
conventional CT and MRI scans. Specialized functional
or metabolic sequences such as SPECT (Single Photon
Emission Computed Tomography), functional MRI, or
CT perfusion may detect subtle impairments in regional
activity to explain the post-concussive phenomenon [4].
Therapy for post-concussive syndrome is typically sup-
portive. Physical, occupational and behavioral therapies
are the mainstay of treatment, and the vast majority of* Correspondence: shoja.m@gmail.com
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baseline in under a year. Recently, hyperbaric oxygen
therapy (HBOT) has been used as a potential therapeutic
option for patients experiencing chronic PCS symptoms
[5]. HBOT involves the administration of oxygen at
supra-atmospheric pressures and increased fractions of
inspired air.
HBOT is increasingly used to treat the long-term se-
quelae of a variety of neurologic conditions, including is-
chemic stroke, subarachnoid hemorrhage, and recently
mild TBI [5-7]. HBOT is thought to induce neuroplasti-
city, support repair of injured brain tissue, and stimulate
angiogenesis [8]. Although considered a largely benign
intervention, increasing pressures beyond four to five
absolute atmospheres is associated with oxygen toxicity
and lowering of the seizure threshold [9]. Due to its fa-
vorable safety profile, limitations to the use of HBOT are
mainly financial and practical. Therapeutic sessions re-
quire a significant time investment on the part of the pa-
tient, and a single session typically costs several hundred
dollars [10].
Treatment paradigms are not standardized across
studies on the use of HBOT in TBI. Atmospheric pres-
sure, length of treatment, and number of sessions all vary
between studies. With rare exception, 100% oxygen is
used [11]. A typical HBOT session might consist of thirty
to sixty minutes administration of 100% oxygen at 1.5 to
2.5 times atmospheric pressure. Patients typically undergo
twenty to sixty sessions over four to twelve weeks, based
on the condition being treated [12]. The optimal paradigm
for HBOT in TBI remains to be determined.
Invasive and expensive interventions such as HBOT
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ies on HBOT are difficult to perform, as patients are able
to sense even minor changes in atmospheric pressure. In
a recent study, Boussi-Gross et al. attempt to address
this issue through the use of a prospective, randomized,
crossover trial to evaluate the impact of HBOT on pa-
tients with chronic post-concussive syndrome years after
mild TBI [14]. Fifty six patients with PCS of greater than
one year’s duration were randomized to receive forty
HBOT sessions either before or after a two month con-
trol period. Patients were evaluated by standardized cog-
nitive testing, quality-of-life questionnaires, and SPECT
imaging at several points during the study period. Both
groups showed statistically significant improvements in
cognitive function, quality of life, and fronto-temporal
perfusion on SPECT imaging following HBOT, but not
following the control period. All SPECT analysis was
blinded to the laboratory and clinical data, and showed
increased brain perfusion in regions critical for higher-
order cognition and memory.
While the study design allowed for both inter- and
intra-group comparisons before and after HBOT admin-
istration, it did not completely address the potential role
of the placebo effect in these patients. Other investiga-
tors have utilized control groups in which patients were
randomized to increased atmospheric pressures with a
normal atmospheric partial pressure of oxygen. In gen-
eral, these studies have not shown a benefit of either in-
creased oxygen tension or increased pressures to 1.5 to
2 times atmospheric pressure [15,16]. However these
studies do not address any potential therapeutic benefit
of higher pressures in the absence of increased oxygen
tension. As of 2012, the Cochrane Collaboration stated
that HBOT could not be routinely recommended for
PCS following TBI [17]. Inadequate power in many stud-
ies, variable therapeutic protocol, and methodological
flaws all prevented a positive recommendation.
Nevertheless, the study of Boussi-Gross et al. provides
a compelling argument that whatever the underlying
therapeutic mechanism, patients show improved cogni-
tive function and cerebral perfusion after HBOT, and re-
port improved quality of life. PCS is a debilitating
complication of mild TBI, currently without any defini-
tive treatment options. These results are worth future
investigation in the form of larger randomized, blinded
controlled trials, as well as longer follow-up periods to
determine the durability of any HBOT effect.
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